Shandong Wohua Pharmaceutical Co., Ltd.

Total Valuation

Shandong Wohua Pharmaceutical Co., Ltd. carries a market capitalization of 3.77B, placing it among publicly traded companies globally. Its enterprise value stands at 2.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Shandong Wohua Pharmaceutical Co., Ltd. currently has 577.21M shares outstanding.

Valuation Ratios

Shandong Wohua Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 46.70. The price-to-sales ratio is 4.12, and the price-to-book ratio stands at 4.70.

Enterprise Valuation

On an enterprise value basis, Shandong Wohua Pharmaceutical Co., Ltd. trades at an EV/EBITDA multiple of 39.38 and an EV/FCF ratio of 1,551.89. The EV/Sales ratio of 3.60 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 39.38 provides insight into valuation relative to core operating earnings.

Financial Position

Shandong Wohua Pharmaceutical Co., Ltd. maintains a current ratio of 2.34, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.22, indicating conservative leverage, while an interest coverage ratio of 1,556.42 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Shandong Wohua Pharmaceutical Co., Ltd. posts a return on equity of 10.58 and a return on invested capital of 8.49.

Taxes

Over the trailing twelve months, Shandong Wohua Pharmaceutical Co., Ltd. has paid 10.41M in income taxes, reflecting an effective tax rate of 13.75.

Stock Price Statistics

Shandong Wohua Pharmaceutical Co., Ltd.'s stock has gained approximately 10.10101% over the past 52 weeks. The 50-day moving average sits at 6.60, while the 200-day moving average is 6.69.

Income Statement

Over the trailing twelve months, Shandong Wohua Pharmaceutical Co., Ltd. generated 794.00M in revenue and converted that into 70.00M in net income, yielding earnings per share of 0.11. EBITDA reached 72.55M, while operating income came in at 72.55M.

Balance Sheet

Shandong Wohua Pharmaceutical Co., Ltd. holds 431.48M in cash and equivalents against 1.69M in total debt, resulting in a net debt position of -431.48M. Total book value stands at 695.77M, with working capital of 352.35M providing operational flexibility.

Cash Flow

After subtracting -1.80M in capital expenditures, free cash flow totaled -1.80M - equivalent to 0.00 per share.

Margins

Shandong Wohua Pharmaceutical Co., Ltd. operates with a gross margin of 73.65, reflecting its pricing power and cost economics. The operating margin of 9.14 and net profit margin of 8.82 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Shandong Wohua Pharmaceutical Co., Ltd.'s most recent stock split took place on May 29, 2020 with a 5:8 split ratio.

Scores

Shandong Wohua Pharmaceutical Co., Ltd. posts an Altman Z-Score of 8.65, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.